Table 3. . Performance of the Framingham Risk Score and atherosclerotic cardiovascular disease Pooled Cohort risk estimators in the Framingham Heart Study and Intermountain Healthcare cohorts.
| Risk estimator | Dataset | Sensitivity | Specificity |
|---|---|---|---|
| Framingham Risk Score | FHS | ||
| Overall | 0.15 | 0.93 | |
| Males | 0.12 | 0.86 | |
| Females | 0.22 | 0.98 | |
| IM | |||
| Overall | 0.31 | 0.89 | |
| Males | 0.33 | 0.85 | |
| Females | 0.29 | 0.93 | |
| ASCVD Pooled Cohort Equation | FHS | ||
| Overall | 0.41 | 0.74 | |
| Males | 0.52 | 0.66 | |
| Females | 0.18 | 0.81 | |
| IM | |||
| Overall | 0.69 | 0.55 | |
| Males | 0.78 | 0.61 | |
| Females | 0.57 | 0.5 | |
ASCVD: atherosclerotic cardiovascular disease; FHS: Framingham Heart Study; IM: Intermountain Healthcare.